Home LiteratureArticle Details
PMID: 3920147 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Recognition of serogroup A Neisseria meningitidis serotype antigens by human antisera.

Infection and immunity ·Vol. 48 ·No. 1 ·1985-04-00 ·Pages 23-8

Sugasawara RJ

Abstract

The antigens of Neisseria meningitidis serogroup A which were recognized by human antisera were identified by Western blot and enzyme-linked immunosorbent assay techniques. The components of six prototype strains used for serotyping serogroup A meningococci were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to nitrocellulose for immunoperoxidase staining with sera collected from 10 acute-phase and 14 convalescent-phase patients. Six acute-phase sera detected six major antigens having apparent molecular weights between 14,000 and 82,000. In addition to recognizing these antigens, the convalescent-phase sera detected a protease-sensitive antigen with an apparent molecular weight of 20,000 for one strain and 27,000 for five strains, lipopolysaccharide, and the heat-modifiable proteins. The sera recognized lipopolysaccharide in a serotype-specific manner, whereas their reactions with the heat-modifiable protein were not serotype specific. Convalescent-phase sera recognized components from eight meningococcal serogroups. The concentrations of immunoglobulin G directed to capsular polysaccharide were determined by the enzyme-linked immunosorbent assay; seven acute-phase sera had less than 0.39 micrograms of antibody per ml, whereas the average concentration in convalescent-phase sera was 3.22 micrograms/ml and the range was 0.40 to 7.50 micrograms/ml.

MeSH Terms
Adolescent Adult Antigens, Bacterial/analysis Child Child, Preschool Cross Reactions Enzyme-Linked Immunosorbent Assay Female Humans Immune Sera/immunology Immunoglobulin G/analysis Male Middle Aged Molecular Weight Neisseria meningitidis/immunology
Chemicals
Antigens, Bacterial Immune Sera Immunoglobulin G
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Sugasawara R J
References (31)
31 references, click to expand
  1. Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.
    J Exp Med. 1969 Jun 1;129(6):1349-65 PMID: 4977282
  2. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
    J Infect Dis. 1977 Aug;136 Suppl:S43-50 PMID: 408432
  3. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies.
    J Immunol Methods. 1981;46(2):129-40 PMID: 6171594
  4. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.
    Infect Immun. 1977 Nov;18(2):424-33 PMID: 72735
  5. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  6. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease.
    J Infect Dis. 1977 Dec;136(6):733-9 PMID: 925381
  7. Human immunity to the meningococcus. I. The role of humoral antibodies.
    J Exp Med. 1969 Jun 1;129(6):1307-26 PMID: 4977280
  8. Immunogenicity of meningococcal antigens as detected in patient sera.
    Infect Immun. 1983 Apr;40(1):398-406 PMID: 6131872
  9. Homogeneity of protein serotype antigens in Neisseria meningitidis group A.
    Infect Immun. 1977 May;16(2):623-7 PMID: 405327
  10. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.
    J Exp Med. 1969 Jun 1;129(6):1367-84 PMID: 4977283
  11. Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine.
    J Clin Microbiol. 1980 Aug;12(2):256-63 PMID: 6785306
  12. Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays.
    Infect Immun. 1974 Nov;10(5):975-84 PMID: 16558113
  13. Enzyme-linked immunosorbent assay with a monoclonal antibody for detecting group A meningococcal antigens in cerebrospinal fluid.
    J Clin Microbiol. 1984 Feb;19(2):230-4 PMID: 6142055
  14. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  15. Quantitative determination of the human immune response to immunization with meningococcal vaccines.
    J Clin Invest. 1972 Jan;51(1):89-96 PMID: 4621363
  16. Epidemiological value of lipopolysaccharide and heat-modifiable outer-membrane protein serotyping of group-A strains of Neisseria meningitidis.
    J Med Microbiol. 1982 Aug;15(3):327-30 PMID: 6811746
  17. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity.
    J Exp Med. 1974 Jul 1;140(1):87-104 PMID: 4134571
  18. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
    J Infect Dis. 1981 Jan;143(1):32-41 PMID: 6783703
  19. Human immunity to the meningococcus. II. Development of natural immunity.
    J Exp Med. 1969 Jun 1;129(6):1327-48 PMID: 4977281
  20. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland.
    Scand J Infect Dis. 1978;10(1):41-4 PMID: 635475
  21. Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.
    Infect Immun. 1980 May;28(2):451-8 PMID: 6156902
  22. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.
    Immunochemistry. 1971 Sep;8(9):871-4 PMID: 5135623
  23. The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.
    Trans N Y Acad Sci. 1965 Jun;27(8):1003-54 PMID: 5318403
  24. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.
    J Infect Dis. 1980 Dec;142(6):861-8 PMID: 6780634
  25. Statistical package for analysis of competition ELISA results.
    J Immunol Methods. 1981;47(3):375-85 PMID: 7037971
  26. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.
    J Infect Dis. 1977 Aug;136 Suppl:S31-5 PMID: 408431
  27. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.
    J Infect Dis. 1973 Apr;127(4):378-87 PMID: 4121052
  28. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.
    Anal Biochem. 1981 Apr;112(2):195-203 PMID: 6266278
  29. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.
    J Infect Dis. 1979 Nov;140(5):690-7 PMID: 118997
  30. Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine.
    J Infect Dis. 1983 Oct;148(4):767 PMID: 6605394
  31. Antibody responses to meningococcal polysaccharide vaccines.
    Infect Immun. 1973 Oct;8(4):590-6 PMID: 4200543
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1985-04-00
Pages
23-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC261908
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]